T-group (topology)
3010.1.1 C-terminal subdomain in Lon-related proteases catalytic domains
Ligands and drugs
821
Member domains
98
with ligand contacts (≤ 4 Å)
11.9% of members
88
with DrugDomain annotations
10.7% of members
67
with a DrugBank compound
8.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3010.1.1 belongs to X-group 3010 C-terminal subdomain in Lon-related proteases catalytic domains, which has 9 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00188 | BO2 | Bortezomib | 22 |
| DB03345 | BME | Mercaptoethanol | 5 |
| DB00536 | GAI | Guanidine | 4 |
| DB00139 | SIN | Succinic acid | 2 |
| DB03904 | URE | Urea | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 31 |
| 4KZ | N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 11 |
| GAI | GUANIDINE | 6 |
| BME | BETA-MERCAPTOETHANOL | 5 |
| CAmetal | CALCIUM ION | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| NAmetal | SODIUM ION | 2 |
| SIN | SUCCINIC ACID | 2 |
| UFY | N-[(1R)-1-borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide | 2 |
| UKS | [(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid | 2 |
| CIX | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | 1 |
| CL | CHLORIDE ION | 1 |
| SLA | Omuralide, open form | 1 |
| URE | UREA | 1 |